Only differentiated thyroid cancer (mainly papillary and follicular carcinomas) can be considered for iodine 131 therapy, but it is contraindicated in pregnancy, lactation, planned short-term (6-month) pregnancy; in those who are unable to follow radiation protection instructions; and not recommended in those with cancer foci smaller than 1 cm and without extra-glandular infiltration, lymph nodes or distant metastases.